We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · June 20, 2020

Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced HNSCC

Journal of Clinical Oncology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Oncology
Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study
J. Clin. Oncol 2020 Jun 01;[EPub Ahead of Print], SF Powell, KA Gold, MM Gitau, CJ Sumey, MM Lohr, SC McGraw, RK Nowak, AW Jensen, MJ Blanchard, CD Fischer, J Bykowski, CA Ellison, LJ Black, PA Thompson, JL Callejas-Valera, JH Lee, EEW Cohen, WC Spanos

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading